back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-12-23 16:59 Tx date 2022-12-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$72,500
+1,450,000 vol $0.05 each |
2,647,837 | |
| Filed 2022-12-22 17:11 Tx date 2022-12-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$560.00
+16,000 vol $0.035 each |
1,197,837 | |
| Filed 2022-12-21 17:07 Tx date 2022-12-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$630.00
+18,000 vol $0.035 each |
1,181,837 | |
| Filed 2022-12-15 21:05 Tx date 2022-12-15 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+15,000 vol $0.03 each |
1,163,837 | |
| Filed 2022-12-05 15:59 Tx date 2022-12-03 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-11,000
-100,000 vol $0.11 each |
50,000 | |
| Filed 2022-05-26 13:12 Tx date 2022-05-25 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110.00
+1,000 vol $0.11 each |
1,148,837 | |
| Filed 2022-05-24 11:23 Tx date 2022-05-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$880.00
+8,000 vol $0.11 each |
1,147,837 | |
| Filed 2022-02-02 14:46 Tx date 2022-02-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+20,000 vol $0.135 each |
478,000 | |
| Filed 2022-01-26 18:22 Tx date 2021-12-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-7,000
-7,000 vol $1.00 each |
255,000 | |
| Filed 2022-01-26 18:17 Tx date 2022-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-2,500
-5,000 vol $0.50 each |
250,000 | |
| Filed 2022-01-26 17:31 Tx date 2022-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$6,000
+100,000 vol $0.06 each |
200,000 | |
| Filed 2022-01-26 17:17 Tx date 2022-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,000
-100,000 vol $0.06 each |
158,500 | |
| Filed 2021-12-23 18:16 Tx date 2021-12-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-3,500
-3,500 vol $1.00 each |
||
| Filed 2021-12-23 18:16 Tx date 2021-12-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-3,500
-3,500 vol $1.00 each |
258,500 | |
| Filed 2021-11-21 12:46 Tx date 2021-11-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$25,000
+250,000 vol $0.10 each |
1,139,837 | |
| Filed 2021-11-21 12:45 Tx date 2021-11-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
$-4,683.70
-46,837 vol $0.10 each |
0 | |
| Filed 2021-11-21 12:44 Tx date 2021-11-21 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-25,000
-250,000 vol $0.10 each |
46,837 | |
| Filed 2021-04-11 14:52 Tx date 2021-04-07 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,315
-49,500 vol $0.37 each |
889,837 | |
| Filed 2021-04-11 14:51 Tx date 2021-04-07 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-200.00
-500 vol $0.40 each |
939,337 | |
| Filed 2021-03-11 15:29 Tx date 2021-03-11 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$14,000
+140,000 vol $0.10 each |
939,837 | |
| Filed 2021-03-11 15:27 Tx date 2021-03-11 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-14,000
-140,000 vol $0.10 each |
296,837 | |
| Filed 2021-03-04 00:48 Tx date 2021-03-01 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,437.50
-12,500 vol $0.275 each |
799,837 | |
| Filed 2021-03-04 00:47 Tx date 2021-03-01 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,890
-7,000 vol $0.27 each |
812,337 | |
| Filed 2021-02-24 16:43 Tx date 2021-02-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$27,000
+270,000 vol $0.10 each |
819,337 | |
| Filed 2021-02-24 16:42 Tx date 2021-02-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-27,000
-270,000 vol $0.10 each |
436,837 | |
| Filed 2021-02-24 16:36 Tx date 2021-02-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-600.00
-2,000 vol $0.30 each |
549,337 | |
| Filed 2021-02-24 16:36 Tx date 2021-02-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,250
-25,000 vol $0.25 each |
551,337 | |
| Filed 2021-02-24 16:36 Tx date 2021-02-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,000
-25,000 vol $0.24 each |
576,337 | |
| Filed 2021-02-24 16:35 Tx date 2021-02-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,500
-20,000 vol $0.225 each |
601,337 | |
| Filed 2021-02-24 16:35 Tx date 2021-02-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,150
-15,000 vol $0.21 each |
621,337 | |
| Filed 2021-02-22 09:26 Tx date 2021-02-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,000
-25,000 vol $0.20 each |
636,337 | |
| Filed 2021-02-22 09:25 Tx date 2021-02-18 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,382.50
-34,500 vol $0.185 each |
661,337 | |
| Filed 2021-02-17 18:35 Tx date 2021-02-17 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-20,000 vol $0.15 each |
695,837 | |
| Filed 2021-02-17 18:35 Tx date 2021-02-16 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,875
-25,000 vol $0.155 each |
715,837 | |
| Filed 2021-02-17 18:34 Tx date 2021-02-12 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-310.00
-2,000 vol $0.155 each |
740,837 | |
| Filed 2021-02-10 21:31 Tx date 2021-02-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,250
-50,000 vol $0.145 each |
742,837 | |
| Filed 2021-01-28 15:38 Tx date 2021-01-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$14,000
+140,000 vol $0.10 each |
792,837 | |
| Filed 2021-01-28 15:37 Tx date 2021-01-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-14,000
-140,000 vol $0.10 each |
706,837 | |
| Filed 2020-12-30 15:58 Tx date 2020-08-31 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-50,000 vol |
0 | |
| Filed 2020-12-30 15:52 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
171,000 | |
| Filed 2020-12-30 15:50 Tx date 2020-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
262,000 | |
| Filed 2020-01-31 21:06 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
||
| Filed 2020-12-06 16:29 Tx date 2020-12-03 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
525,000 | |
| Filed 2020-12-06 16:23 Tx date 2020-12-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,045
-9,500 vol $0.11 each |
652,837 | |
| Filed 2020-12-06 16:23 Tx date 2020-12-01 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,215
-55,500 vol $0.13 each |
662,337 | |
| Filed 2020-12-06 16:23 Tx date 2020-12-01 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,060
-46,000 vol $0.11 each |
717,837 | |
| Filed 2020-12-03 17:53 Tx date 2020-11-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
230,000 | |
| Filed 2020-12-03 17:51 Tx date 2020-12-03 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,500
+250,000 vol $0.11 each |
480,000 | |
| Filed 2020-12-03 17:47 Tx date 2020-11-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,000
+150,000 vol $0.06 each |
302,700 | |
| Filed 2020-12-03 17:12 Tx date 2020-12-03 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
845,000 | |
| Filed 2020-12-03 16:59 Tx date 2020-12-03 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,000
+100,000 vol $0.11 each |
266,000 | |
| Filed 2020-12-03 16:57 Tx date 2020-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-3,250
-5,000 vol $0.65 each |
166,000 | |
| Filed 2020-12-03 16:41 Tx date 2020-12-03 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,000
+100,000 vol $0.11 each |
||
| Filed 2020-11-29 23:10 Tx date 2020-11-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-330.00
-3,000 vol $0.11 each |
763,837 | |
| Filed 2020-11-29 23:10 Tx date 2020-11-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,045
-9,500 vol $0.11 each |
766,837 | |
| Filed 2020-11-29 23:10 Tx date 2020-11-25 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55.00
-500 vol $0.11 each |
776,337 | |
| Filed 2020-11-29 23:09 Tx date 2020-11-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,650
-15,000 vol $0.11 each |
776,837 | |
| Filed 2020-11-20 17:54 Tx date 2020-11-17 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,812.50
-38,500 vol $0.125 each |
791,837 | |
| Filed 2020-11-20 17:54 Tx date 2020-11-17 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,920
-16,000 vol $0.12 each |
830,337 | |
| Filed 2020-11-20 17:53 Tx date 2020-11-17 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55.00
-500 vol $0.11 each |
846,337 | |
| Filed 2020-11-16 16:58 Tx date 2020-11-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-250,000 vol $0.06 each |
225,000 | |
| Filed 2020-11-16 16:51 Tx date 2020-11-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+250,000 vol $0.06 each |
||
| Filed 2020-11-16 16:50 Tx date 2020-11-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+250,000 vol $0.06 each |
||
| Filed 2020-11-16 16:20 Tx date 2020-11-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+250,000 vol $0.06 each |
546,950 | |
| Filed 2020-11-06 19:48 Tx date 2020-11-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-250,000 vol $0.06 each |
445,000 | |
| Filed 2020-11-06 19:44 Tx date 2020-11-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+250,000 vol $0.06 each |
458,000 | |
| Filed 2020-11-02 11:26 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
846,837 | ||
| Filed 2020-11-02 11:24 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
846,837 | ||
| Filed 2020-05-26 16:52 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2020-05-26 16:51 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-22 13:44 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-25 21:02 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,098,713 vol |
1,098,713 | |
| Filed 2020-05-24 17:44 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,098,713 vol |
||
| Filed 2020-05-24 18:24 Tx date 2020-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$4,468
+89,372 vol $0.05 each |
89,372 | |
| Filed 2020-05-24 17:44 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,098,713 vol |
1,098,713 | |
| Filed 2020-05-24 17:42 Tx date 2019-01-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-24 17:39 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$65,922
+1,098,713 vol $0.06 each |
1,198,713 | |
| Filed 2020-05-24 17:39 Tx date 2020-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
+100,000 vol |
||
| Filed 2020-05-24 17:39 Tx date 2020-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
+100,000 vol |
100,000 | |
| Filed 2020-05-24 17:37 Tx date 2019-01-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-22 13:44 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2020-05-22 13:43 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$6,000
+100,000 vol $0.06 each |
152,700 | |
| Filed 2020-02-13 21:54 Tx date 2020-02-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$240.00
+3,000 vol $0.08 each |
208,000 | |
| Filed 2020-02-07 14:38 Tx date 2020-02-05 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$975.00
+15,000 vol $0.065 each |
296,950 | |
| Filed 2020-02-07 13:26 Tx date 2020-02-05 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97.50
+1,500 vol $0.065 each |
||
| Filed 2020-02-07 13:26 Tx date 2020-02-05 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97.50
+1,500 vol $0.065 each |
283,450 | |
| Filed 2020-01-31 21:06 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
171,000 | |
| Filed 2020-01-31 21:05 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
396,000 | |
| Filed 2020-01-31 21:03 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
||
| Filed 2020-01-31 21:03 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$7,500
+50,000 vol $0.15 each |
||
| Filed 2020-01-31 21:00 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
||
| Filed 2020-01-31 20:58 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$7,500
+50,000 vol $0.15 each |
50,000 | |
| Filed 2020-01-31 20:58 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$7,500
+50,000 vol $0.15 each |
||
| Filed 2020-01-31 20:54 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+5,000 vol |
346,000 | |
| Filed 2020-01-31 20:48 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+3,500 vol |
341,000 | |
| Filed 2020-01-31 20:46 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+3,500 vol |
337,500 | |
| Filed 2020-01-31 20:44 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+4,000 vol |
334,000 | |
| Filed 2020-01-31 20:42 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+5,000 vol |
330,000 | |
| Filed 2020-01-31 20:37 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-210,000 vol |
325,000 | |
| Filed 2020-01-31 20:11 Tx date 2019-08-25 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-325,000 vol |
21,000 | |
| Filed 2020-01-29 12:13 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
475,000 | |
| Filed 2020-01-27 23:49 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
380,000 | |
| Filed 2020-01-27 22:09 Tx date 2020-01-27 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
695,000 | |
| Filed 2020-01-24 18:15 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
||
| Filed 2020-01-24 18:06 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
||
| Filed 2020-01-24 16:40 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
||
| Filed 2020-01-24 16:40 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
475,000 | |
| Filed 2020-01-24 16:30 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
||
| Filed 2020-01-24 16:30 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
||
| Filed 2020-01-24 13:51 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
||
| Filed 2020-01-24 13:51 Tx date 2020-01-24 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
380,000 | |
| Filed 2019-11-07 17:20 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+200,000 vol $0.15 each |
230,000 | |
| Filed 2019-11-07 17:18 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-07 17:18 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2019-11-07 17:14 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-07 17:13 Tx date 2007-02-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-07 17:13 Tx date 2007-02-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-07 17:06 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-469,800 vol |
52,700 | |
| Filed 2019-11-07 17:04 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Holder: Tracie Catalano (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-56,070 vol |
6,230 | |
| Filed 2019-11-07 16:57 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-526,320 vol |
||
| Filed 2019-11-07 16:57 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-526,320 vol |
-3,820 | |
| Filed 2018-12-21 19:06 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2007-02-26 13:52 Tx date 2007-02-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2007-02-26 13:49 Tx date 2007-02-26 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-23 11:59 Tx date 2019-10-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,648
+45,600 vol $0.08 each |
281,950 | |
| Filed 2019-06-13 15:45 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
445,000 | |
| Filed 2019-06-13 15:42 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-315,000 vol |
35,000 | |
| Filed 2019-06-13 15:40 Tx date 2018-11-30 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,050,000 vol |
350,000 | |
| Filed 2019-06-13 15:39 Tx date 2018-11-30 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,100,000 vol |
||
| Filed 2019-06-13 15:34 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-405,000 vol |
45,000 | |
| Filed 2019-06-13 15:33 Tx date 2018-10-25 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
450,000 | |
| Filed 2019-06-13 15:21 Tx date 2019-05-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,845,000 vol |
205,000 | |
| Filed 2019-06-05 15:57 Tx date 2019-05-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
225,000 | |
| Filed 2019-06-05 15:55 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 15:53 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
236,350 | |
| Filed 2019-06-05 15:52 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
136,350 | ||
| Filed 2019-06-05 15:48 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+50,000 vol |
50,000 | |
| Filed 2019-06-05 15:45 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 15:44 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 15:44 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
||
| Filed 2019-06-05 15:42 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$7,500
+50,000 vol $0.15 each |
||
| Filed 2019-06-05 15:37 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$7,500
+50,000 vol $0.15 each |
||
| Filed 2019-06-05 15:33 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
||
| Filed 2019-06-05 15:29 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 15:22 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$7,500
+50,000 vol $0.15 each |
50,000 | |
| Filed 2019-06-05 15:19 Tx date 2009-03-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 15:17 Tx date 2019-06-04 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2019-06-05 15:14 Tx date 2009-03-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2018-12-21 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Holder: Tracie Catalano (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
62,300 | ||
| Filed 2018-12-21 Tx date 2018-12-20 |
$APC
Advanced Proteome Therapeutics Corporation |
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
522,500 | ||
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$17,500
+350,000 vol $0.05 each |
2,050,000 | |
| Filed 2018-08-23 Tx date 2018-06-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$26,250
+350,000 vol $0.075 each |
1,400,000 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+400,000 vol $0.05 each |
400,000 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+400,000 vol $0.05 each |
1,750,000 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+400,000 vol $0.075 each |
400,000 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+400,000 vol $0.075 each |
1,350,000 | |
| Filed 2018-08-23 Tx date 2018-06-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-19 Tx date 2018-06-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+1,000,000 vol $0.06 each |
1,000,000 | |
| Filed 2018-06-14 Tx date 2018-06-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-14 Tx date 2018-06-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-14 Tx date 2018-06-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-17 Tx date 2018-05-17 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+300,000 vol $0.055 each |
500,000 | |
| Filed 2018-05-17 Tx date 2018-05-17 |
$APC
Advanced Proteome Therapeutics Corporation |
Garrett, John R.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+300,000 vol $0.055 each |
475,000 | |
| Filed 2018-04-20 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,050,000 | ||
| Filed 2018-04-20 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-04-20 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,700,000 | ||
| Filed 2018-04-19 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Garrett, John R.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
175,000 | ||
| Filed 2018-04-19 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Garrett, John R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-19 Tx date 2018-04-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Garrett, John R.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Skinner, Thom
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,625
+225,000 vol $0.065 each |
350,000 | |
| Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,250
+50,000 vol $0.065 each |
535,000 | |
| Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,000
+200,000 vol $0.065 each |
2,700,000 | |
| Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,000
+200,000 vol $0.065 each |
325,000 | |
| Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,250
+250,000 vol $0.065 each |
1,890,000 | |
| Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$12,000
+120,000 vol $0.10 each |
164,791 | |
| Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$120,000
+1,200,000 vol $0.10 each |
||
| Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$6,000
+120,000 vol $0.05 each |
234,583 | |
| Filed 2017-09-29 Tx date 2017-09-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+1,200,000 vol $0.05 each |
||
| Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+41,666 vol |
44,791 | |
| Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+3,125 vol |
3,125 | |
| Filed 2017-07-12 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Rights 4 rights will entitle the holder to subscribe for 1 unit
57 - Exercise of rights
|
$-375.00
-25,000 vol $0.015 each |
0 | |
| Filed 2017-07-12 Tx date 2017-06-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Rights 4 rights will entitle the holder to subscribe for 1 unit
56 - Grant of rights
|
+25,000 vol |
25,000 | |
| Filed 2017-07-12 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Rights 4 rights will entitle the holder to subscribe for 1 unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,999
+83,333 vol $0.06 each |
114,583 | |
| Filed 2017-07-12 Tx date 2017-07-10 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$375.00
+6,250 vol $0.06 each |
31,250 | |
| Filed 2017-06-14 Tx date 2017-06-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Skinner, Thom
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,250
+125,000 vol $0.05 each |
125,000 | |
| Filed 2017-06-14 Tx date 2017-06-09 |
$APC
Advanced Proteome Therapeutics Corporation |
Skinner, Thom
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2017-06-12 |
$APC
Advanced Proteome Therapeutics Corporation |
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2017-06-13 |
$APC
Advanced Proteome Therapeutics Corporation |
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,250
+125,000 vol $0.05 each |
125,000 | |
| Filed 2017-06-13 Tx date 2017-06-12 |
$APC
Advanced Proteome Therapeutics Corporation |
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2017-06-12 |
$APC
Advanced Proteome Therapeutics Corporation |
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-09 Tx date 2017-02-08 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+25,000 vol $0.08 each |
25,000 | |
| Filed 2017-02-09 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-07 Tx date 2017-02-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,640,000 | |
| Filed 2017-01-26 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$12,600
+252,000 vol $0.05 each |
302,000 | |
| Filed 2017-01-26 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
500,000 | |
| Filed 2017-01-26 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,600
+252,000 vol $0.05 each |
2,892,000 | |
| Filed 2017-01-25 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,500
+50,000 vol $0.05 each |
485,000 | |
| Filed 2017-01-24 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
2,500,000 | |
| Filed 2017-01-24 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Hayes, Gary Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+115,000 vol |
650,000 | |
| Filed 2017-01-24 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+140,000 vol |
640,000 | |
| Filed 2017-01-24 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Bellin, Jean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
650,000 | |
| Filed 2017-01-09 Tx date 2016-12-22 |
$APC
Advanced Proteome Therapeutics Corporation |
1090573 B.C. Ltd.
2 - Subsidiary of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$200,000
+4,000,000 vol $0.05 each |
4,000,000 | |
| Filed 2017-01-09 Tx date 2016-09-23 |
$APC
Advanced Proteome Therapeutics Corporation |
1090573 B.C. Ltd.
2 - Subsidiary of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-29 Tx date 2016-09-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jane Woodward (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2016-12-29 Tx date 2016-09-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2016-12-29 Tx date 2016-09-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
| Filed 2016-12-29 Tx date 2016-09-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jane Woodward (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
87,000 | ||
| Filed 2016-12-29 Tx date 2016-09-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,640,000 | ||
| Filed 2016-10-31 Tx date 2016-10-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+600,000 vol |
950,000 | |
| Filed 2016-10-31 Tx date 2016-10-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+600,000 vol $0.05 each |
1,350,000 | |
| Filed 2016-05-19 Tx date 2016-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+350,000 vol |
350,000 | |
| Filed 2016-05-19 Tx date 2007-02-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-19 Tx date 2016-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+700,000 vol $0.05 each |
750,000 | |
| Filed 2016-05-19 Tx date 2016-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Bellin, Jean
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+129,000 vol |
129,000 | |
| Filed 2016-05-19 Tx date 2008-12-09 |
$APC
Advanced Proteome Therapeutics Corporation |
Bellin, Jean
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-19 Tx date 2016-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Bellin, Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,900
+258,000 vol $0.05 each |
258,000 | |
| Filed 2016-05-19 Tx date 2008-12-09 |
$APC
Advanced Proteome Therapeutics Corporation |
Bellin, Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-31 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,000
+40,000 vol $0.05 each |
435,000 | |
| Filed 2015-12-30 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
2,350,000 | |
| Filed 2015-12-30 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
500,000 | |
| Filed 2015-12-30 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Bellin, Jean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
525,000 | |
| Filed 2015-12-30 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Hayes, Gary Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
535,000 | |
| Filed 2015-06-02 Tx date 2015-06-02 |
$APC
Advanced Proteome Therapeutics Corporation |
Chase, Randal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 |